期刊文献+

血管紧张素Ⅱ与基质金属蛋白酶关系研究进展

Advances in Relationship Between Angiotensin Ⅱ and Matrix Metalloproteinases
下载PDF
导出
摘要 目前研究表明,在急性冠脉综合征发生过程中基质金属蛋白酶家族与斑块性质变化有密切关系。血管紧张素Ⅱ作为肾素-血管紧张素系统最重要效应因子也在动脉粥样硬化的发生发展病理过程起关键作用。近年来有较多研究探讨血管紧张素Ⅱ与基质金属蛋白酶之间的关系及其内在机制,现就此进行综述。 Angiotensin Ⅱ is widely recognized as a critical regulator of the development of atherosclerosis. Matrix metalloproteinases are thought to participate in plaque destabilization through degradation of the extraeellular matrix in the process of acute coronary syndrome. Studies have increasingly focused attention on these interactions. This article reviews progress in research into the relationship between angiotensin Ⅱ and matrix metalloproteinases.
作者 刘宏 杨丽霞
出处 《心血管病学进展》 CAS 2009年第3期515-517,共3页 Advances in Cardiovascular Diseases
关键词 血管紧张素Ⅱ 基质金属蛋白酶 急性冠脉综合征 angiotensin Ⅱ matrix metalloproteinases aeute coronary syndrome
  • 相关文献

参考文献19

  • 1Mehta PK,Griendling KK.Angiotensin Ⅱ cell signaling:physiological and pathological effects in the cardiovascular system[R].Am J Physiol Cell Physiol,2007,292(1):C82-97.
  • 2Nanni S,Melandri G,Hanemaaijer R,et al.Matrix metalloproteinases in premature coronary atherosclerosis:influence of inhibitors,inflammation,and genetic polymorphisms[J].Transl Res,2007,149(3):137-144.
  • 3Ribichini F,Pugno F,Ferrero V,et al Cellular immunostaining of angiotensin-converting enzyme in human coronary atherosclerotic plaques[J].J Am Coll Cardiol,2006,47(6):1143-1149.
  • 4Galis ZS,Khatri JJ.Matrix metalloproteinases in vascular remodeling and atherogenesis:the good,the bad,and the ugly[R].Circ Res,2002,90(3):251-262.
  • 5Stacy LB,Yu Q,Horak K,et al.Effect of angiotensin Ⅱ on primary cardiac fibroblast matrix metalloproteinase activities[J].Perfusion,2007,22(1):51-55.
  • 6Schmidt R,Bultmann A,Fischel S,et al.Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets,activates platelets,and augments nuclear factor kappaB-dependent inflammation in monocytes[J].Circ Res,2008,102(3):302-309.
  • 7Schieffer B,Bunte C,Witte J,et al.Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease[J].J Am Coll Cardiol,2004,44(2):362-368.
  • 8Arenas IA,Xu Y,Lopez-Jaramillo P,et al.Angiotensin Ⅱ-induced MMP-2 release from endothelial cells is mediated by TNF-alpha[J].Am J Physiol Cell Physiol,2004,286(4):C779-784.
  • 9Cipollone F,Fazia M,Iezzi A,et al.Blockade of the angiotensin Ⅱ type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity[J].Circulation,2004,109(12):1482-1488.
  • 10Kim MP,Zhou M,Wahl LM.Angiotensin Ⅱ increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2:implications for atherosclerotic plaque rupture[J].J Leukoc Biol,2005,78(1):195-201.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部